|
시장보고서
상품코드
1812422
아세트아미노펜 시장 : 제품 형태별, 투여 경로별, 용도별, 제품 유형별, 판매 유형별, 연령층별, 성별, 농도별, 유통 채널별, 최종 사용자별, 지역별Acetaminophen Market, By Product Form, By Route of Administration, By Application, By Product Type, By Sales Type, By Age Group, By Gender, By Strength, By Distribution Channel, By End User, By Geography |
||||||
아세트아미노펜 시장은 2025년에 104억 6,000만 달러, 2032년에는 144억 3,000만 달러에 이르고, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 4.7%로 성장할 것으로 예측되고 있습니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 104억 6,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2020-2024년 |
| 예측기간 2025-2032년 CAGR : | 4.70% | 2032년 가치 예측 | 144억 3,000만 달러 |
세계의 아세트아미노펜 시장은 세계에서 가장 널리 사용되는 상용 진통 및 해열제 중 하나이며 의약품 업계에서 중요한 부분입니다. 아세트아미노펜은 많은 지역에서 파라세타몰이라고도 불리며, 다양한 인구 집단에서 통증 관리 및 해열을 위한 기본적인 치료제 역할을 합니다. 이 필수적인 의약품은 수십 년간의 임상 검증을 통해 경도에서 중등도의 통증 상태에 대한 일관된 효능을 나타내며, 적절하게 사용되었을 때 양호한 안전성 프로파일을 보여줌으로써 시장에서 우위를 유지해 왔습니다.
이 시장은 정제, 캡슐제, 현탁액제, 배합제 등 다양한 제제를 갖추고 있으며, 소아, 성인, 노인 환자 집단을 모두 대상으로 하고 있습니다. 제조 사업은 기존 제약 기지와 신흥 시장에 걸쳐 있으며, 생산 능력은 다국적 기업과 지역 기업 모두에 분산되어 있습니다. 아세트아미노펜이 세계 필수 의약품 목록에 포함되어 있고, 대체 진통제에 비해 비용 효과가 높고, 다양한 국가에서 폭넓게 규제 승인을 받았다는 점이 시장의 견고함으로 이어지고 있습니다. 약국의 소매 채널과 슈퍼마켓, 심지어 전자상거래 플랫폼을 통해 소비자들이 쉽게 입수할 수 있는 것도 아세트아미노펜 시장에서의 입지를 더욱 견고하게 만들고 있습니다. 또한 새로운 전달 메커니즘과 병용 요법에 대한 지속적인 연구가 이 확립된 의약품 부문의 혁신을 뒷받침하고 있습니다.
시장 역학
세계의 아세트아미노펜 시장은 다수의 치료 용도 및 지역 수요를 종합적으로 향상시키는 여러 상호 관련 요소에 의해 강력한 성장을 이루고 있습니다. 주요 시장 성장 촉진요인으로는 만성 통증 질환의 세계적인 확산, 정기적인 통증 관리 솔루션을 필요로 하는 노인 인구 증가, 비스테로이드성 항염증제(NSAIDs)와 비교하여 아세트아미노펜의 안전성 프로파일이 양호하다는 인식 증가 등이 있습니다. 아세트아미노펜은 시판약의 입수가능성이 확대되고 자가 치료를 선호하는 소비자가 늘어나면서 시장 진입 가능성이 크게 높아지고 있습니다.
또한, 아세트아미노펜은 다른 유효한 의약 성분과의 조합 제형에 범용성이 있기 때문에 치료 효용성과 시장 매력도를 더욱 높이고 있습니다. 그러나 시장은 간독성 우려로 인한 복용량 제한을 규정하는 엄격한 규제 체제, 대체 통증 관리 요법과의 경쟁 증가, 과다 복용 시 발생할 수 있는 부작용에 대한 소비자 인식 증가 등 여러 제약 요인에 직면해 있습니다. 원료 가격 변동과 공급망 혼란과 관련된 제조 과제는 시장 성장 가능성을 더욱 제한합니다. 반대로 약물전달 시스템의 기술적 진보, 서방형 제제의 개발, 헬스케어 인프라가 부족한 지역 시장으로의 진출을 통해 상당한 기회가 창출되고 있습니다.
본 조사의 주요 특징
- 아세트아미노펜 세계 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에서 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 아세트아미노펜 세계 시장에서 주요 기업 프로파일은 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 기반으로 게재됩니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 아세트아미노펜 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 아세트아미노펜 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 아세트아미노펜 시장, 제품 형태별, 2020년-2032년
- 정제
- 현탁액
- 캡슐
- 좌약
- 기타(분말 및 과립 등)
제5장 세계의 아세트아미노펜 시장, 투여 경로별, 2020년-2032년
- 경구
- 비경구
- 기타(직장 등)
제6장 세계의 아세트아미노펜 시장, 용도별, 2020년-2032년
- 통증 관리(경증, 중등도, 심한 통증)
- 해열
- 기타(감기 및 인플루엔자 치료 등)
제7장 세계의 아세트아미노펜 시장, 제품 유형별, 2020년-2032년
- 단일제제(아세트아미노펜만)
- 복합제제(아세트아미노펜과 오피오이드, NSAIDs, 항히스타민제, 또는 충혈제거제)
제8장 세계의 아세트아미노펜 시장, 판매 유형별, 2020년-2032년
- 일반의약품(OTC)
- 처방
제9장 세계의 아세트아미노펜 시장, 연령층별, 2020년-2032년
- 성인
- 소아
- 고령자
제10장 세계의 아세트아미노펜 시장, 성별, 2020년-2032년
- 남성
- 여성
제11장 세계의 아세트아미노펜 시장, 농도별, 2020년-2032년
- 저용량(최대 325mg)
- 표준(500mg)
- 고용량(500mg 초과)
제12장 세계의 아세트아미노펜 시장, 유통 채널별, 2020년-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제13장 세계의 아세트아미노펜 시장, 최종 사용자별, 2020년-2032년
- 병원
- 클리닉
- 재택치료
- 기타(간병 시설, 응급 의료 유닛)
제14장 세계의 아세트아미노펜 시장, 지역별, 2020년-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제15장 경쟁 구도
- GlaxoSmithKline(GSK)
- Kenvue
- Haleon
- Sanofi
- Abbott
- Reckitt
- MICRO LABS LTD.
- Taisho Pharmaceutical
- Teva Pharmaceutical Industries
- Reddy's Laboratories
- Aurobindo Pharma
- Sun Pharmaceutical Industries
- Granules India
- Perrigo Company
제16장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제17장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
Acetaminophen Market is estimated to be valued at USD 10.46 Bn in 2025 and is expected to reach USD 14.43 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 10.46 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.70% | 2032 Value Projection: | USD 14.43 Bn |
The global acetaminophen market represents a critical segment within the pharmaceutical industry, encompassing one of the world's most widely used over-the-counter analgesic and antipyretic medications. Acetaminophen, also known as paracetamol in many regions, serves as a cornerstone therapeutic agent for pain management and fever reduction across diverse demographic populations. This essential pharmaceutical compound has maintained its market prominence through decades of clinical validation, demonstrating consistent efficacy in treating mild to moderate pain conditions while exhibiting a favorable safety profile when used appropriately.
The market encompasses various formulations including tablets, capsules, liquid suspensions, and combination products, catering to pediatric, adult, and geriatric patient populations globally. Manufacturing operations span across established pharmaceutical hubs and emerging markets, with significant production capacities distributed among both multinational corporations and regional players. The market's resilience stems from acetaminophen's inclusion in essential medicine lists worldwide, its cost-effectiveness compared to alternative analgesics, and its widespread regulatory approval across numerous jurisdictions. Consumer accessibility through pharmacy retail channels, supermarkets, and increasingly through e-commerce platforms has further solidified acetaminophen's market position, while ongoing research into novel delivery mechanisms and combination therapies continues to drive innovation within this established pharmaceutical segment.
Market Dynamics
The global acetaminophen market experiences robust growth driven by several interconnected factors that collectively enhance demand across multiple therapeutic applications and geographic regions. Primary market drivers include the escalating global prevalence of chronic pain conditions, increasing geriatric populations requiring regular pain management solutions, and rising awareness of acetaminophen's favorable safety profile compared to non-steroidal anti-inflammatory drugs (NSAIDs). The expanding over-the-counter availability and consumer preference for self-medication practices significantly boost market accessibility, while growing healthcare expenditure in emerging economies creates substantial opportunities for market penetration.
Additionally, the versatility of acetaminophen in combination formulations with other active pharmaceutical ingredients enhances its therapeutic utility and market appeal. However, the market faces considerable restraints including stringent regulatory frameworks governing dosage limitations due to hepatotoxicity concerns, increasing competition from alternative pain management therapies, and growing consumer awareness of potential adverse effects associated with overdose scenarios. Manufacturing challenges related to raw material price volatility and supply chain disruptions further constrain market growth potential. Conversely, significant opportunities emerge through technological advancements in drug delivery systems, development of sustained-release formulations, and expansion into underserved geographic markets with limited healthcare infrastructure.
Key features of the study
- This report provides in-depth analysis of the global acetaminophen market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global acetaminophen market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GlaxoSmithKline (GSK), Kenvue, Haleon, Sanofi, Abbott, Reckitt, MICRO LABS LTD., Taisho Pharmaceutical, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Sun Pharmaceutical Industries, Granules India, and Perrigo Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global acetaminophen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acetaminophen market
Market Segmentation
- Product Form Insights (Revenue, USD Bn, 2020 - 2032)
- Tablets
- Liquid Suspensions
- Capsules
- Suppositories
- Others (Powder/Granules, etc.)
- Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral
- Others (Rectal, etc.)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Pain Management (Mild, Moderate, Severe Pain)
- Fever Reduction
- Others (Cold and Flu Treatment, etc.)
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Single Formulation (Acetaminophen-only)
- Combination Formulations (Acetaminophen with opioids, NSAIDs, antihistamines, or decongestants)
- Sales Type Insights (Revenue, USD Bn, 2020 - 2032)
- OTC (Over-the-Counter)
- Prescription
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- Strength Insights (Revenue, USD Bn, 2020 - 2032)
- Low (up to 325 mg)
- Standard (500 mg)
- High (above 500 mg)
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Clinics
- Homecare Settings
- Others (Nursing Homes, Emergency Care Units)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GlaxoSmithKline (GSK)
- Kenvue
- Haleon
- Sanofi
- Abbott
- Reckitt
- MICRO LABS LTD.
- Taisho Pharmaceutical
- Teva Pharmaceutical Industries
- Reddy's Laboratories
- Aurobindo Pharma
- Sun Pharmaceutical Industries
- Granules India
- Perrigo Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Acetaminophen Market, By Product Form
- Global Acetaminophen Market, By Route of Administration
- Global Acetaminophen Market, By Application
- Global Acetaminophen Market, By Product Type
- Global Acetaminophen Market, By Sales Type
- Global Acetaminophen Market, By Age Group
- Global Acetaminophen Market, By Gender
- Global Acetaminophen Market, By Strength
- Global Acetaminophen Market, By Distribution Channel
- Global Acetaminophen Market, By End User
- Global Acetaminophen Market, By Country
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Acetaminophen Market, By Product Form, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Liquid Suspensions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Suppositories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Powder/Granules, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Acetaminophen Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Rectal, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Acetaminophen Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pain Management (Mild, Moderate, Severe Pain)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fever Reduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Cold and Flu Treatment, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Acetaminophen Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Single Formulation (Acetaminophen-only)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Combination Formulations (Acetaminophen with opioids, NSAIDs, antihistamines, or decongestants)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Acetaminophen Market, By Sales Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- OTC (Over-the-Counter)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Acetaminophen Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Acetaminophen Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Acetaminophen Market, By Strength, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Low (up to 325 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Standard (500 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High (above 500 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Acetaminophen Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
13. Global Acetaminophen Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Nursing Homes, Emergency Care Units)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
14. Global Acetaminophen Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
15. Competitive Landscape
- GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kenvue
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haleon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reckitt
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MICRO LABS LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Taisho Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Granules India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Perrigo Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
17. References and Research Methodology
- References
- Research Methodology
- About us
